2023
DOI: 10.1155/2023/9807476
|View full text |Cite
|
Sign up to set email alerts
|

Retracted: The Correlation between Serum Sclerostin Level and Arterial Stiffness in Peritoneal Dialysis Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…Another study selected 50 Parkinson’s disease patients undergoing peritoneal dialysis (PD) to investigate the relationship between Sclerostin levels and arterial stiffness. The results showed a significant correlation between the severity of arterial stiffness and high levels of Sclerostin in PD patients, indicating that elevated serum Sclerostin levels are a risk factor for the progression of atherosclerosis [ 27 ]. In a study by Qureshi et al [ 28 ], 89 ESRD patients who underwent kidney transplantation were evaluated for the extent of vascular calcification (VC) using abdominal aortic and coronary artery calcification (CAC) scores.…”
Section: Discussionmentioning
confidence: 99%
“…Another study selected 50 Parkinson’s disease patients undergoing peritoneal dialysis (PD) to investigate the relationship between Sclerostin levels and arterial stiffness. The results showed a significant correlation between the severity of arterial stiffness and high levels of Sclerostin in PD patients, indicating that elevated serum Sclerostin levels are a risk factor for the progression of atherosclerosis [ 27 ]. In a study by Qureshi et al [ 28 ], 89 ESRD patients who underwent kidney transplantation were evaluated for the extent of vascular calcification (VC) using abdominal aortic and coronary artery calcification (CAC) scores.…”
Section: Discussionmentioning
confidence: 99%